The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device - A MADIT-CRT substudy

Mehmet K. Aktas, Wojciech Zareba, David T. Huang, Scott McNitt, Slava Polonsky, Leway Chen, Martin Stockburger, B. Merkely, Arthur J. Moss, Valentina Kutyifa

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background There are no data regarding the effect of weight loss on clinical outcomes in patients undergoing cardiac resynchronization therapy. This study was designed to evaluate the effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy with defibrillator (CRT-D). Methods and Results The risk of heart failure (HF) or death, and of death alone, was compared between patients with and without weight loss of ≥2 kg or more at 1 year in the CRT-D arm of the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Weight loss was observed in 170 of 994 patients (17%) implanted with a CRT-D. Multivariate analysis showed a significant increase in the risk of HF or death among patients with weight loss compared with those without weight loss (hazard ratio [HR] 1.82, 95% confidence interval [CI] 1.26-2.63; P =.001). Weight loss was associated with a 79% increase in the risk of all-cause mortality (HR 1.79, 95% CI 1.16-3.34; P =.01). When analyzed in a continuous fashion, each kg of weight loss was associated with a 4% increase in the risk of HF or death (P =.03). In left bundle branch block (LBBB) patients with a CRT-D, weight loss was associated with an especially high risk of HF or death (HR 2.23, 95% CI 1.36-3.65; P =.002) and of death alone (HR 2.33, 95% CI 1.07-5.06; P =.03; interaction P =.26). Conclusions In patients with mild symptoms of HF receiving CRT-D, weight loss observed at 1 year is associated with adverse clinical outcomes, especially in those with a LBBB electrocardiographic pattern.

Original languageEnglish
Pages (from-to)183-189
Number of pages7
JournalJournal of Cardiac Failure
Volume20
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy
Defibrillators
Weight Loss
Heart Failure
Confidence Intervals
Bundle-Branch Block
Multivariate Analysis

Keywords

  • cardiac resynchronization therapy
  • left bundle branch block
  • Weight loss

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device - A MADIT-CRT substudy. / Aktas, Mehmet K.; Zareba, Wojciech; Huang, David T.; McNitt, Scott; Polonsky, Slava; Chen, Leway; Stockburger, Martin; Merkely, B.; Moss, Arthur J.; Kutyifa, Valentina.

In: Journal of Cardiac Failure, Vol. 20, No. 3, 2014, p. 183-189.

Research output: Contribution to journalArticle

Aktas, Mehmet K. ; Zareba, Wojciech ; Huang, David T. ; McNitt, Scott ; Polonsky, Slava ; Chen, Leway ; Stockburger, Martin ; Merkely, B. ; Moss, Arthur J. ; Kutyifa, Valentina. / The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device - A MADIT-CRT substudy. In: Journal of Cardiac Failure. 2014 ; Vol. 20, No. 3. pp. 183-189.
@article{0ba995b9acb841949d655c6c8e10d255,
title = "The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device - A MADIT-CRT substudy",
abstract = "Background There are no data regarding the effect of weight loss on clinical outcomes in patients undergoing cardiac resynchronization therapy. This study was designed to evaluate the effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy with defibrillator (CRT-D). Methods and Results The risk of heart failure (HF) or death, and of death alone, was compared between patients with and without weight loss of ≥2 kg or more at 1 year in the CRT-D arm of the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Weight loss was observed in 170 of 994 patients (17{\%}) implanted with a CRT-D. Multivariate analysis showed a significant increase in the risk of HF or death among patients with weight loss compared with those without weight loss (hazard ratio [HR] 1.82, 95{\%} confidence interval [CI] 1.26-2.63; P =.001). Weight loss was associated with a 79{\%} increase in the risk of all-cause mortality (HR 1.79, 95{\%} CI 1.16-3.34; P =.01). When analyzed in a continuous fashion, each kg of weight loss was associated with a 4{\%} increase in the risk of HF or death (P =.03). In left bundle branch block (LBBB) patients with a CRT-D, weight loss was associated with an especially high risk of HF or death (HR 2.23, 95{\%} CI 1.36-3.65; P =.002) and of death alone (HR 2.33, 95{\%} CI 1.07-5.06; P =.03; interaction P =.26). Conclusions In patients with mild symptoms of HF receiving CRT-D, weight loss observed at 1 year is associated with adverse clinical outcomes, especially in those with a LBBB electrocardiographic pattern.",
keywords = "cardiac resynchronization therapy, left bundle branch block, Weight loss",
author = "Aktas, {Mehmet K.} and Wojciech Zareba and Huang, {David T.} and Scott McNitt and Slava Polonsky and Leway Chen and Martin Stockburger and B. Merkely and Moss, {Arthur J.} and Valentina Kutyifa",
year = "2014",
doi = "10.1016/j.cardfail.2013.12.012",
language = "English",
volume = "20",
pages = "183--189",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device - A MADIT-CRT substudy

AU - Aktas, Mehmet K.

AU - Zareba, Wojciech

AU - Huang, David T.

AU - McNitt, Scott

AU - Polonsky, Slava

AU - Chen, Leway

AU - Stockburger, Martin

AU - Merkely, B.

AU - Moss, Arthur J.

AU - Kutyifa, Valentina

PY - 2014

Y1 - 2014

N2 - Background There are no data regarding the effect of weight loss on clinical outcomes in patients undergoing cardiac resynchronization therapy. This study was designed to evaluate the effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy with defibrillator (CRT-D). Methods and Results The risk of heart failure (HF) or death, and of death alone, was compared between patients with and without weight loss of ≥2 kg or more at 1 year in the CRT-D arm of the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Weight loss was observed in 170 of 994 patients (17%) implanted with a CRT-D. Multivariate analysis showed a significant increase in the risk of HF or death among patients with weight loss compared with those without weight loss (hazard ratio [HR] 1.82, 95% confidence interval [CI] 1.26-2.63; P =.001). Weight loss was associated with a 79% increase in the risk of all-cause mortality (HR 1.79, 95% CI 1.16-3.34; P =.01). When analyzed in a continuous fashion, each kg of weight loss was associated with a 4% increase in the risk of HF or death (P =.03). In left bundle branch block (LBBB) patients with a CRT-D, weight loss was associated with an especially high risk of HF or death (HR 2.23, 95% CI 1.36-3.65; P =.002) and of death alone (HR 2.33, 95% CI 1.07-5.06; P =.03; interaction P =.26). Conclusions In patients with mild symptoms of HF receiving CRT-D, weight loss observed at 1 year is associated with adverse clinical outcomes, especially in those with a LBBB electrocardiographic pattern.

AB - Background There are no data regarding the effect of weight loss on clinical outcomes in patients undergoing cardiac resynchronization therapy. This study was designed to evaluate the effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy with defibrillator (CRT-D). Methods and Results The risk of heart failure (HF) or death, and of death alone, was compared between patients with and without weight loss of ≥2 kg or more at 1 year in the CRT-D arm of the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Weight loss was observed in 170 of 994 patients (17%) implanted with a CRT-D. Multivariate analysis showed a significant increase in the risk of HF or death among patients with weight loss compared with those without weight loss (hazard ratio [HR] 1.82, 95% confidence interval [CI] 1.26-2.63; P =.001). Weight loss was associated with a 79% increase in the risk of all-cause mortality (HR 1.79, 95% CI 1.16-3.34; P =.01). When analyzed in a continuous fashion, each kg of weight loss was associated with a 4% increase in the risk of HF or death (P =.03). In left bundle branch block (LBBB) patients with a CRT-D, weight loss was associated with an especially high risk of HF or death (HR 2.23, 95% CI 1.36-3.65; P =.002) and of death alone (HR 2.33, 95% CI 1.07-5.06; P =.03; interaction P =.26). Conclusions In patients with mild symptoms of HF receiving CRT-D, weight loss observed at 1 year is associated with adverse clinical outcomes, especially in those with a LBBB electrocardiographic pattern.

KW - cardiac resynchronization therapy

KW - left bundle branch block

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=84896100090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896100090&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2013.12.012

DO - 10.1016/j.cardfail.2013.12.012

M3 - Article

VL - 20

SP - 183

EP - 189

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 3

ER -